Citations per year, relative to H Freeman H Freeman (= 1×)
peers
Norman A. Todd
Countries citing papers authored by H Freeman
Since
Specialization
Citations
This map shows the geographic impact of H Freeman's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by H Freeman with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites H Freeman more than expected).
This network shows the impact of papers produced by H Freeman. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by H Freeman. The network helps show where H Freeman may publish in the future.
Co-authorship network of co-authors of H Freeman
This figure shows the co-authorship network connecting the top 25 collaborators of H Freeman.
A scholar is included among the top collaborators of H Freeman based on the total number of
citations received by their joint publications. Widths of edges
represent the number of papers authors have co-authored together.
Node borders
signify the number of papers an author published with H Freeman. H Freeman is excluded from
the visualization to improve readability, since they are connected to all nodes in the network.
All Works
20 of 20 papers shown
1.
Nieuwenhuizen, Ch. van, H. Katschnig, H Freeman, & Norman Sartorius. (2006). Measuring quality of life in mental disorders : Some new developments.. 85–90.6 indexed citations
2.
Oosterhuis, Harry, et al.. (2005). Psychiatric Cultures Compared. Psychiatry and Mental Health Care in the Twentieth Century.12 indexed citations
3.
Feldstein, Aaron, et al.. (1998). A preliminary report on MAO inhibition and clincial effectiveness in the treatment of depressed patients with phenelzine.. PubMed. 2. 12–4.2 indexed citations
Freeman, H. (1977). Long-acting neuroleptics and their place in community mental health services in the United Kingdom: the Salford experience.. PubMed. 76(5). 786–91.1 indexed citations
11.
Freeman, H. (1974). A double-blind comparison of mesoridazine and chlorpromazine in chronic schizophrenics.. PubMed. 34(6). 289–93.6 indexed citations
Freeman, H, et al.. (1972). A double-blind comparison of the efficacy of EX 10-029 and trihexyphenidyl hydrochloride in relieving drug-induced Parkinsonian symptoms.. PubMed. 14(8). 470–7.1 indexed citations
14.
Freeman, H, et al.. (1969). Comparison of trifluoperazine and molindone in chronic schizophrenic patients.. PubMed. 11(11). 670–6.13 indexed citations
15.
Freeman, H, et al.. (1968). A double-blind study of SKF 14336 vs. trifluoperazine in schizophrenic patients.. PubMed. 10(10). 537–42.1 indexed citations
16.
Freeman, H. (1967). The therapeutic value of combinations of psychotropic drugs: a review.. PubMed. 4(1). 1–27.17 indexed citations
17.
Freeman, H, et al.. (1966). Towards a community mental health service 1954-65.. PubMed. 25. 24–30.4 indexed citations
18.
Feldstein, Aaron, et al.. (1965). MAO inhibition and antidepressant activity.. PubMed. 1(4). 384–7.3 indexed citations
19.
Freeman, H, et al.. (1960). A clinical evaluation of marplan in depressed patients.. PubMed. 21(3)Suppl. 104–6.3 indexed citations
20.
Freeman, H, et al.. (1956). Effects of chlorpromazine and reserpine in chronic schizophrenic patients.. PubMed. 17(7). 213–9.11 indexed citations
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive
bibliographic database. While OpenAlex provides broad and valuable coverage of the global
research landscape, it—like all bibliographic datasets—has inherent limitations. These include
incomplete records, variations in author disambiguation, differences in journal indexing, and
delays in data updates. As a result, some metrics and network relationships displayed in
Rankless may not fully capture the entirety of a scholar's output or impact.